The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Debreceni Egyetem. Általános Orvostudományi Kar. Biokémiai és Molekuláris Biológiai Intézet / University of Debrecen. Faculty of Medicine. Department of Biochemistry and Molecular Biology
Korponay-Szabó, I.,
Király, R.,
Gyimesi, J.,
Mäki, M.:
Development of Cell-Assembled Human Endomysial-Type Biomatrix Substrate for the Detection of Celiac Disease Autoantibodies.
Int. J. Mol. Sci. 26 (3), 1-18, (article identifier: 1012), 2025.
Diós, Á.,
Elek, R.,
Szabó, I.,
Horváth, S.,
Gyimesi, J.,
Király, R.,
Werkstetter, K.,
Koletzko, S.,
Fésüs, L.,
Korponay-Szabó, I.:
Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction.
Amino Acids. 53 (7), 1051-1063, 2021.
Csobán-Szabó, Z.,
Fésüs, L.,
Király, R.:
Protein-peptide based assay for the characterization of human blood coagulation factor XIII-A isopeptidase activity.
Anal. Biochem. 600, 1-8, (article identifier: 113699), 2020.
Ulukan, B.,
Bihorac, A.,
Sipahioglu, T.,
Király, R.,
Fésüs, L.,
Telci, D.:
Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression.
ACS Omega. 5 (43), 28273-28284, 2020.
Aladdin, A.,
Király, R.,
Botó, P.,
Regdon, Z.,
Tar, K.:
Juvenile Huntington's disease skin fibroblasts respond with elevated parkin level and increased proteasome activity as a potential mechanism to counterbalance the pathological consequences of mutant huntingtin protein.
Int. J. Mol. Sci. 20 (21), 1-39, (article identifier: 5338), 2019.
Sivadó, É.,
El Alaoui, M.,
Király, R.,
Fésüs, L.,
Delolme, F.,
Page, A.,
El Alaoui, S.:
Optimised methods (SDS/PAGE and LC-MS) reveal deamidation in all examined transglutaminase-mediated reactions.
FEBS Open Bio. 9 (2), 396-404, 2019.
Q2
Biochemistry, Genetics and Molecular Biology (miscellaneous)
2018
13.
Fésüs, L.,
Király, R.:
Transzglutamináz.
In: Ezerarcú fehérjék. Szerk.: Buday László, Nyitray László, Perczel András, Semmelweis Kiadó, Budapest, 737-748, 2018. ISBN: 9789633314586
Thangaraju, K.,
Király, R.,
Demény, M. Á.,
Mótyán, J. A.,
Fuxreiter, M.,
Fésüs, L.:
Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2.
PLoS One. 12 (3), 1-24, (article identifier: 0172189), 2017.
Q2
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q2
Medicine (miscellaneous)
2016
17.
Király, R.,
Thangaraju, K.,
Nagy, Z.,
Collighan, R.,
Nemes, Z.,
Griffin, M.,
Fésüs, L.:
Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters.
Amino Acids. 48 (1), 31-40, 2016.
Biri, B.,
Kiss, B.,
Király, R.,
Schlosser, G.,
Láng, O.,
Kőhidai, L.,
Fésüs, L.,
Nyitray, L.:
Metastasis-associated S100A4 is a specific amine donor and an activity-independent binding partner of transglutaminase-2.
Biochem. J. 473 (1), 31-42, 2016.
Thangaraju, K.,
Biri, B.,
Schlosser, G.,
Kiss, B.,
Nyitray, L.,
Fésüs, L.,
Király, R.:
Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein substrate.
Anal. Biochem. 505, 36-42, 2016.
Korponay-Szabó, I.,
Kerekes-Tóth, B.,
Gyimesi, J.,
Bartáné Tóth, B.,
Kissné Bogáti, R.,
Király, R.,
Caja, S.,
Nadalutti, C.,
Lindfors, K.,
Mäki, M.,
Fésüs, L.:
Search for gluten non-dependent prospective biomarkers for in vitro diagnostic use: 16th International Coeliac Disease Symposium 21-24 June 2015, Prague.
Kanchan, K.,
Ergülen, E.,
Király, R.,
Simon-Vecsei, Z.,
Fuxreiter, M.,
Fésüs, L.:
Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity.
Biochem. J. 455 (3), 261-272, 2013.
Tóth, B.,
Kissné Bogáti, R.,
Király, R.,
Simon-Vecsei, Z.,
Caja, S.,
Bartáné Tóth, B.,
Nadalutti, C.,
Lindfors, K.,
Mäki, M.,
Fésüs, L.,
Korponay-Szabó, I.:
Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2.
JPGN. 56 (Suppl_2), 200, 2013.
Tóth, B.,
Kissné Bogáti, R.,
Király, R.,
Simon-Vecsei, Z.,
Caja, S.,
Bartáné Tóth, B.,
Nadalutti, C.,
Lindfors, K.,
Mäki, M.,
Fésüs, L.,
Korponay-Szabó, I.:
Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2: 46th Annual Meeting of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).
Király, R.,
Barta, E.,
Fésüs, L.:
Polymorphism of transglutaminase 2: unusually low frequency of genomic variants with deficient functions.
Amino Acids. 44 (1), 215-225, 2013.
